Evidence map›Paper›PMID 20675382›Full record

ArticleThe Journal of biological chemistry2010

CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.

Jen-Liang Su, Jean Chiou, Chih-Hsin Tang, Ming Zhao, Chun-Hao Tsai, Pai-Sheng Chen, Yi-Wen Chang, Ming-Hsien Chien, Chu-Ying Peng, Michael Hsiao and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Identification of Genes Related to Rapid Growth of Giant Grouper (Animals : an open access journal from MDPI · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Jen-Liang SuGraduate Institute of Cancer Biology, College of Medicine, and the eGraduate Institute of Basic Medical Science, China Medical University, Taichung 404,Taiwan.
Jean Chiou
Chih-Hsin Tang
Ming Zhao
Chun-Hao Tsai
Pai-Sheng Chen
Yi-Wen Chang
Ming-Hsien Chien
Chu-Ying Peng
Michael Hsiao
Ming-Liang Kuo
Men-Luh Yen
National Taiwan University Hospital · TWChina Medical University · TWAngiogenesis Foundation · USAsia University · TWCenter for Molecular Medicine and Immunology · USDrug Discovery Laboratory (Norway) · NOGenomics Research Center, Academia Sinica · TWPost Graduate Medical Institute · PKUniversity of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is one of the most common bone pathologies. A number of novel molecules have been reported to increase bone formation including cysteine-rich protein 61 (CYR61), a ligand of integrin receptor, but mechanisms remain unclear. It is known that bone morphogenetic proteins (BMPs), especially BMP-2, are crucial regulators of osteogenesis. However, the interaction between CYR61 and BMP-2 is unclear. We found that CYR61 significantly increases proliferation and osteoblastic differentiation in MC3T3-E1 osteoblasts and primary cultured osteoblasts. CYR61 enhances mRNA and protein expression of BMP-2 in a time- and dose-dependent manner. Moreover, CYR61-mediated proliferation and osteoblastic differentiation are significantly decreased by knockdown of BMP-2 expression or inhibition of BMP-2 activity. In this study we found integrin α(v)β(3) is critical for CYR61-mediated BMP-2 expression and osteoblastic differentiation. We also found that integrin-linked kinase, which is downstream of the α(v)β(3) receptor, is involved in CYR61-induced BMP-2 expression and subsequent osteoblastic differentiation through an ERK-dependent pathway. Taken together, our results show that CYR61 up-regulates BMP-2 mRNA and protein expression, resulting in enhanced cell proliferation and osteoblastic differentiation through activation of the α(v)β(3) integrin/integrin-linked kinase/ERK signaling pathway.

Indexed as

AnimalsBone Morphogenetic Protein 2Cell DifferentiationCell LineCell ProliferationCysteine-Rich Protein 61Dose-Response Relationship, DrugExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, EnzymologicIntegrin alphaVbeta3MAP Kinase Signaling SystemMiceOsteoblastsProtein Serine-Threonine KinasesScaffold Protein ILKTime FactorsBmp2 protein, mouseBone Morphogenetic Protein 2CCN1 protein, mouseCysteine-Rich Protein 61Extracellular Signal-Regulated MAP KinasesIntegrin alphaVbeta3Protein Serine-Threonine KinasesScaffold Protein ILK

Identifiers

PMID20675382
PMCPMC2951207
OpenAlexW2006409326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.